1. Search Result
Search Result
Results for "

ACT-128800

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-10569
    Ponesimod

    ACT-128800

    LPL Receptor Inflammation/Immunology
    Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation.